A study that included 46 DLBCL has identified TRAIL-R1 or TRAIL-R2 mutations in 5 of them (10.9%), all of which were inside or in close proximity to the region encoding the death domain [95]. This evidence concerns the gene TNFRSF10B and diffuse large B-cell lymphoma.